Jank P, Lindner JL, Lehmann A, Pfitzner BM, et al. Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict). Breast Cancer Res Treat 2021 Nov 16. pii: 10.1007/s10549-021-06415.
PMID: 34783927